Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors

Experimental Hematology

Volumn 24, Issue 8, 1996, Pages 868-874

  Torcia, M ^a   Lucibello, M ^a   Vannier, E ^a   Fabiani, S ^a   Miliani, A ^a   Guidi, G ^a   Spada, O ^a   Dower, S K ^a   Sims, J E ^a   Shaw, A R ^a   Dinarello, C A ^a   Garaci, E ^a   Cozzolino, F ^a  

^a University of Roma   (Italy)

Author keywords

IL 1 inhibitor; Multiple myeloma; OAF

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECEPTOR SUBTYPE; RECOMBINANT INTERLEUKIN 1BETA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MULTIPLE MYELOMA; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW; BONE MARROW CELLS; BONE RESORPTION; CALCIUM; CELL DIVISION; CELLS, CULTURED; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LYMPHOKINES; LYMPHOTOXIN-ALPHA; MULTIPLE MYELOMA; NEOPLASM STAGING; OSTEOCLASTS; RATS; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0030016476     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)